Trends in the Longitudinal Utilization of Oral Anticoagulants Among Newly Diagnosed Atrial Fibrillation Patients With Commercial, Medicare, and Medicaid Insurance

Am J Cardiol. 2023 Sep 15:203:339-342. doi: 10.1016/j.amjcard.2023.07.037. Epub 2023 Jul 28.
No abstract available

MeSH terms

  • Administration, Oral
  • Aged
  • Anticoagulants / therapeutic use
  • Atrial Fibrillation* / complications
  • Atrial Fibrillation* / diagnosis
  • Atrial Fibrillation* / drug therapy
  • Humans
  • Medicaid
  • Medicare
  • Retrospective Studies
  • Stroke* / epidemiology
  • Stroke* / etiology
  • Stroke* / prevention & control
  • United States / epidemiology
  • Warfarin / therapeutic use

Substances

  • Anticoagulants
  • Warfarin